11/9/2024

Difluprednate Ophthalmic Emulsion

Products Affected - Description

- Difluprednate ophthalmic emulsion, Exelan Pharmaceuticals, 0.05%, 5 mL bottle, 1 count, NDC 76282-0708-50

Reason for the Shortage

- Amneal has difluprednate ophthalmic emulsion available.
- Exelan has difluprednate ophthalmic emulsion on shortage due to manufacturing delays.
- Sandoz has difluprednate and Durezol ophthalmic emulsions available. Durezol's NDC number was recently changed.

Available Products

- Durezol ophthalmic emulsion, Sandoz, 0.05%, 5 mL bottle, 1 count, NDC 66758-0086-75
- Difluprednate ophthalmic emulsion, Amneal, 0.05%, 5 mL bottle, 1 count, NDC 69238-1380-03
- Difluprednate ophthalmic emulsion, Sandoz, 0.05%, 5 mL bottle, 1 count, NDC 00781-6000-78

Estimated Resupply Dates

- Exelan has 0.05% difluprednate 5 mL bottles on long-term back order and the company cannot estimate a release date.

Updated

Updated November 9, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 17, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.